XML 17 R6.htm IDEA: XBRL DOCUMENT v3.21.1
UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF EQUITY - USD ($)
$ in Thousands
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Retained Earnings
Treasury Stock
Cumulative Effect, Period of Adoption, Adjustment
Total
Balance at Jun. 30, 2019 $ 4 $ 713,436 $ (40)   $ 22,447 $ (102,482)   $ 633,365
Balance (in shares) at Jun. 30, 2019 45,575,236         (5,334,743)    
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         (9,730)     (9,730)
Foreign currency translation adjustment     139         139
Stock-based compensation expense   5,594           5,594
Exercise of stock options   42           42
Exercise of stock options (in shares) 2,500              
Issuance of restricted stock awards (in shares) 918,702              
Forfeiture of restricted stock awards (in shares) (34,090)              
Repurchase of restricted stock for tax withholding   (4,698)           (4,698)
Repurchase of restricted stock for tax withholding (in shares) (171,778)              
Balance at Sep. 30, 2019 $ 4 714,374 99   12,717 $ (102,482)   624,712
Balance (in shares) at Sep. 30, 2019 46,290,570         (5,334,743)    
Balance at Jun. 30, 2019 $ 4 713,436 (40)   22,447 $ (102,482)   633,365
Balance (in shares) at Jun. 30, 2019 45,575,236         (5,334,743)    
Increase (Decrease) in Stockholders' Equity                
Net income (loss)               19,618
Balance at Mar. 31, 2020 $ 4 724,992 49   42,065 $ (102,482)   664,628
Balance (in shares) at Mar. 31, 2020 46,274,270         (5,334,743)    
Balance at Sep. 30, 2019 $ 4 714,374 99   12,717 $ (102,482)   624,712
Balance (in shares) at Sep. 30, 2019 46,290,570         (5,334,743)    
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         20,594     20,594
Foreign currency translation adjustment     (287)         (287)
Stock-based compensation expense   6,256           6,256
Exercise of stock options   6           6
Exercise of stock options (in shares) 500              
Issuance of restricted stock awards (in shares) 18,000              
Forfeiture of restricted stock awards (in shares) (18,019)              
Repurchase of restricted stock for tax withholding   (185)           (185)
Repurchase of restricted stock for tax withholding (in shares) (8,878)              
Balance at Dec. 31, 2019 $ 4 720,451 (188)   33,311 $ (102,482)   651,096
Balance (in shares) at Dec. 31, 2019 46,282,173         (5,334,743)    
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         8,754     8,754
Foreign currency translation adjustment     237         237
Stock-based compensation expense   6,162           6,162
Issuance of restricted stock awards (in shares) 108,959              
Forfeiture of restricted stock awards (in shares) (23,900)              
Repurchase of restricted stock for tax withholding   (1,621)           (1,621)
Repurchase of restricted stock for tax withholding (in shares) (92,962)              
Balance at Mar. 31, 2020 $ 4 724,992 49   42,065 $ (102,482)   664,628
Balance (in shares) at Mar. 31, 2020 46,274,270         (5,334,743)    
Balance (ASU 2016-13) at Jun. 30, 2020       $ (6,253)     $ (6,253)  
Balance at Jun. 30, 2020 $ 4 730,761 93   46,953 $ (102,482)   675,329
Balance (in shares) at Jun. 30, 2020 46,341,627         (5,334,743)    
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         12,666     12,666
Foreign currency translation adjustment     (192)         (192)
Stock-based compensation expense   9,009           9,009
Exercise of stock options   32           32
Exercise of stock options (in shares) 948,867              
Withholding of stock options for tax withholding   (10,885)           (10,885)
Withholding of stock options for tax withholding (in shares) (655,219)              
Equity component of convertible senior notes, net of issuance costs and taxes   105,477           105,477
Purchases of capped calls in connection with convertible senior notes   (60,354)           (60,354)
Issuance of restricted stock awards (in shares) 383,223              
Forfeiture of restricted stock awards (in shares) (9,329)              
Repurchase of restricted stock for tax withholding   (5,808)           (5,808)
Repurchase of restricted stock for tax withholding (in shares) (136,194)              
Balance at Sep. 30, 2020 $ 4 768,232 (99)   53,366 $ (102,482)   719,021
Balance (in shares) at Sep. 30, 2020 46,872,975         (5,334,743)    
Balance (ASU 2016-13) at Jun. 30, 2020       $ (6,253)     $ (6,253)  
Balance at Jun. 30, 2020 $ 4 730,761 93   46,953 $ (102,482)   675,329
Balance (in shares) at Jun. 30, 2020 46,341,627         (5,334,743)    
Increase (Decrease) in Stockholders' Equity                
Net income (loss)               $ 60,956
Exercise of stock options (in shares)               988,317
Balance at Mar. 31, 2021 $ 4 788,028 (427)   101,656 $ (102,482)   $ 786,779
Balance (in shares) at Mar. 31, 2021 46,877,934         (5,334,743)    
Balance at Sep. 30, 2020 $ 4 768,232 (99)   53,366 $ (102,482)   719,021
Balance (in shares) at Sep. 30, 2020 46,872,975         (5,334,743)    
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         24,501     24,501
Foreign currency translation adjustment     (270)         (270)
Stock-based compensation expense   9,181           9,181
Exercise of stock options   271           271
Exercise of stock options (in shares) 15,000              
Equity component of convertible senior notes, net of issuance costs and taxes   25           25
Issuance of restricted stock awards (in shares) 19,500              
Forfeiture of restricted stock awards (in shares) (2,122)              
Repurchase of restricted stock for tax withholding   (300)           (300)
Repurchase of restricted stock for tax withholding (in shares) (11,419)              
Balance at Dec. 31, 2020 $ 4 777,409 (369)   77,867 $ (102,482)   752,429
Balance (in shares) at Dec. 31, 2020 46,893,934         (5,334,743)    
Increase (Decrease) in Stockholders' Equity                
Net income (loss)         23,789     23,789
Foreign currency translation adjustment     (58)         (58)
Stock-based compensation expense   12,962           12,962
Exercise of stock options   421           421
Exercise of stock options (in shares) 24,450              
Issuance of restricted stock awards (in shares) 117,085              
Forfeiture of restricted stock awards (in shares) (57,435)              
Repurchase of restricted stock for tax withholding   (2,764)           (2,764)
Repurchase of restricted stock for tax withholding (in shares) (100,100)              
Balance at Mar. 31, 2021 $ 4 $ 788,028 $ (427)   $ 101,656 $ (102,482)   $ 786,779
Balance (in shares) at Mar. 31, 2021 46,877,934         (5,334,743)